Application 021346

Type
NDA
Sponsor
JANSSEN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RISPERDAL CONSTARISPERIDONEINJECTABLE;INTRAMUSCULAR25MG/VIALYesYes
002RISPERDAL CONSTARISPERIDONEINJECTABLE;INTRAMUSCULAR37.5MG/VIALYesNo
003RISPERDAL CONSTARISPERIDONEINJECTABLE;INTRAMUSCULAR50MG/VIALYesNo
004RISPERDAL CONSTARISPERIDONEINJECTABLE;INTRAMUSCULAR12.5MG/VIALYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50458-306RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-306RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-306RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-306RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-306RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-307RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-307RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-307RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-307RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-307RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-308RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-308RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-308RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-308RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-308RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-309RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-309RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-309RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-309RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent
50458-309RISPERDAL CONSTArisperidoneJanssen Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83889SUPPL 2025-10-23
81128SUPPL 2025-02-07
81029SUPPL 2025-02-05
71934SUPPL2022-08-26
71933SUPPL2022-08-26
71921SUPPL2022-08-26
71919SUPPL2022-08-26
71917SUPPL2022-08-26
71916SUPPL2022-08-26
71914SUPPL2022-08-26
71912SUPPL2022-08-26
71910SUPPL2022-08-26
71909SUPPL2022-08-26
71907SUPPL2022-08-26
71905SUPPL2022-08-26
71902SUPPL2022-08-26
71897SUPPL2022-08-26
71895SUPPL2022-08-26
66280SUPPL2021-02-18
66242SUPPL2021-02-17
65868SUPPL2021-01-08
61843SUPPL2020-02-07
61788SUPPL2020-02-06
57556SUPPL2019-02-13
57363SUPPL2019-01-28
55147SUPPL2018-08-09
55053SUPPL2018-07-30
47423SUPPL2017-03-02
47321SUPPL2017-02-24
36722SUPPL2016-03-03
27558SUPPL2016-03-03
36721SUPPL2014-06-10
27557SUPPL2014-05-09
15253SUPPL2014-04-29
27556SUPPL2012-03-13
23648ORIG2011-12-20
27555SUPPL2011-12-13
15250SUPPL2011-12-13
15246SUPPL2011-12-13
5116SUPPL2011-12-13
36719SUPPL2011-09-30
15252SUPPL2011-09-30
27552SUPPL2011-09-28
5121SUPPL2011-09-28
36718SUPPL2011-09-02
27551SUPPL2011-08-26
5120SUPPL2011-06-17
15251SUPPL2011-06-16
5119SUPPL2010-12-06
15249SUPPL2010-12-04
27554SUPPL2010-09-01
27553SUPPL2010-09-01
27550SUPPL2010-09-01
5118SUPPL2010-09-01
36720SUPPL2010-08-30
36717SUPPL2010-08-30
15248SUPPL2010-08-30
15245SUPPL2010-08-30
15247SUPPL2009-08-06
5117SUPPL2009-08-06
36716SUPPL2009-06-07
36714SUPPL2009-06-07
5115SUPPL2009-05-20
5113SUPPL2009-05-20
36715SUPPL2008-11-07
36713SUPPL2008-11-07
36712SUPPL2008-11-07
15244SUPPL2008-11-07
27548SUPPL2008-10-14
5114SUPPL2008-10-14
5112SUPPL2008-10-14
5111SUPPL2008-10-14
27549SUPPL2008-08-19
36711SUPPL2007-04-20
27547SUPPL2007-04-20
15243SUPPL2007-03-15
5110SUPPL2007-03-15
5109SUPPL2006-10-23
27546SUPPL2006-09-25
15242SUPPL2006-09-21
27545SUPPL2006-08-04
27544SUPPL2005-08-19
15241SUPPL2005-08-19
21611ORIG2005-06-16
27543ORIG2003-11-28